comparemela.com

Latest Breaking News On - Novarti enerzair breezhaler - Page 1 : comparemela.com

Connected Drug Delivery Devices Market to Grow at a Significant CAGR of 23 59% by 2028 - Estimates DelveInsight | Adherium, Propeller Health, West Pharmaceutical, BIOCORP, Phillips-Medisize, Merck, Novo Nordisk, Medtronic, Tandem Diabetes Care, Ypsomed, Teva Pharmaceutical, Elcam Medical, Cohero Health |

Global $4 07 Billion Connected Drug Delivery Devices Market to 2028 - Increased Patient Connectivity and Engagement & Rising Patient Awareness

Share this article Share this article ResearchAndMarkets.com s offering. The global connected drug delivery devices market size is expected to reach USD 4.07 billion by 2028 registering a CAGR of 46.7% Factors contributing to the growth of this market include a rise in awareness about the adverse effects of non-adherence to medication and increased adoption of IoT, patient connectivity, and engagement. The Covid-19 pandemic has further accentuated the need for contactless services, thereby increasing the demand for connected drug delivery devices as well as providing lucrative growth opportunities in the coming years. Connected drug delivery devices help physicians to monitor the compliance of patients to the therapy prescribed by them as well as to modify the treatment of the patient treatment as required. A growing number of initiatives to create awareness regarding the complexities caused by overdosage or underdosage of medicines is expected to promote the adoption of conn

Connected drug delivery devices market to grow to $4bn by 2028

Connected drug delivery devices market to grow to $4bn by 2028 1 A new report reveals the COVID-19 pandemic, prevalence of chronic disease and increasing patient engagement will all drive adoption of connected drug delivery devices. The global connected drug delivery devices market is expected to reach a value of $4.07 billion by 2028, registering a compound annual growth rate (CAGR) of 46.7 percent between 2021 and 2028. A new report by Grand View Research suggests that the market expansion will be driven by increasing awareness surrounding the adverse effects of non-adherence to medication, as wells as increased adoption of IoT, patient connectivity and engagement. For instance, the report highlights that there is a growing number of initiatives to create awareness regarding the complexities caused by overdosage or underdosage of medicines and this is anticipated to promote the adoption of connected drug delivery devices.

Global Connected Drug Delivery Devices (Bluetooth, NFC, Other) Market Size, Share & Trends Analysis

Search jobs 01-Mar-2021 Global Connected Drug Delivery Devices (Bluetooth, NFC, Other) Market Size, Share & Trends Analysis Report 2021-2028 - ResearchAndMarkets.com ResearchAndMarkets.com s offering. The global connected drug delivery devices market size is expected to reach USD 4.07 billion by 2028 registering a CAGR of 46.7% Factors contributing to the growth of this market include a rise in awareness about the adverse effects of non-adherence to medication and increased adoption of IoT, patient connectivity, and engagement. The Covid-19 pandemic has further accentuated the need for contactless services, thereby increasing the demand for connected drug delivery devices as well as providing lucrative growth opportunities in the coming years.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.